Get startedLog in
    Picture of Agenus logo

    AGEN — Agenus News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapTurnaround
    All News

    Agenus Inc reports results for the quarter ended December 31 - Earnings Summary

    Picture of Agenus logoAgenus
    11/03/2025 13:32
    Agenus Inc AGEN.OQ reported a quarterly adjusted loss of $2.04​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-2.60.  The mean expectation of five analysts for the quarter was for a loss of $2.54 per share. Wall Street expected results to range from $-3.40 to $-1.56 per share.

Revenue fell 68% to $26.84 million from a year ago; analysts expected $30.27 million.

Agenus Inc's reported EPS for the quarter was a loss of $2.04​.

The company reported a quarterly loss of $46.81 million.

Agenus Inc shares had fallen by 21.5% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 3.6% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell."

The average consensus recommendation for the biotechnology & medical research peer group is also "hold"

Wall Street's median 12-month price target for Agenus Inc is $7.00

This summary was machine generated from LSEG data March 11 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)


    QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
    Dec. 31 2024-2.54-2.04Beat
    Sep. 30 2024-2.33-3.08Missed
    Jun. 30 2024-1.44-2.52Missed
    Mar. 31 2024-3.22-3.04Beat

    Recent news on Agenus

    See all news